Literature DB >> 8141836

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

M I Mackness1, S Arrol, C Abbott, P N Durrington.   

Abstract

We have investigated the Cu2+ induced generation of lipid peroxides in low density lipoprotein (LDL) incubated with high density lipoprotein (HDL) and with purified paraoxonase, an enzyme normally resident on HDL. HDL (1.5 mg) and paraoxonase (20 micrograms) inhibited lipid peroxide generation in LDL by 32% and 25%, respectively after 24 h of incubation (both P < 0.01). The decrease in LDL lipid peroxides both with HDL and with paraoxonase were concentration dependent. The degree of protection offered by HDL tended to relate to its paraoxonase activity (R = 0.47; P < 0.06). Neither purified paraoxonase nor HDL chelated Cu2+ sufficiently to account for the decrease in LDL oxidation. Purified paraoxonase did not affect LDL oxidation when it had been heat inactivated. Mass transfer of lipid peroxides from LDL to HDL did not explain the protection of LDL against oxidation: the total lipid peroxides accumulating during incubation was decreased both by HDL and by paraoxonase. These results suggest a direct role for HDL in preventing atherosclerosis probably by an enzymic process which prevents the accumulation of lipid peroxides on LDL. Paraoxonase is an example of an enzyme which might possibly be involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8141836     DOI: 10.1016/0021-9150(93)90183-u

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  145 in total

1.  Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis.

Authors:  Indranil Banerjee
Journal:  Eur J Epidemiol       Date:  2010-06-09       Impact factor: 8.082

2.  Conway Memorial Lecture 2002. The dyslipidaemia of diabetes: lessons in the pathogenesis of atherosclerosis.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Oct-Dec       Impact factor: 1.568

3.  The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats.

Authors:  Aysel Kiyici; Nilsel Okudan; Hakki Gökbel; Muaz Belviranli
Journal:  J Med Food       Date:  2010-06       Impact factor: 2.786

4.  Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.

Authors:  Luis M Moura; Susana Faria; Miguel Brito; Fausto J Pinto; Steen D Kristensen; Isabel M Barros; Nalini Rajamannan; Francisco Rocha-Gonçalves
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

Review 5.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

6.  Correlation of paraoxonase1 activities with birth weight.

Authors:  Mukund Ramchandra Mogarekar; Mohit Vijay Rojekar
Journal:  Indian J Pediatr       Date:  2013-09-19       Impact factor: 1.967

7.  Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.

Authors:  S A Pereira; J R Batuca; U Caixas; T Branco; J Delgado-Alves; I Germano; F Lampreia; E C Monteiro
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

8.  Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome.

Authors:  K G Lagos; T D Filippatos; V Tsimihodimos; I F Gazi; C Rizos; A D Tselepis; D P Mikhailidis; Moses S Elisaf
Journal:  Lipids       Date:  2008-10-28       Impact factor: 1.880

9.  Coronary artery diseases in South Asian immigrants: an update on high density lipoprotein role in disease prevention.

Authors:  Sunita Dodani
Journal:  J Immigr Minor Health       Date:  2008-09-24

Review 10.  LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.

Authors:  M Aviram; B Fuhrman
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.